Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
Change and processes of change within interventions to promote adjustment to multiple sclerosis: Learning from patient experiences.
Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
One of the oldest patients with Neuromyelitis Optica in the literature.
Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. (MOBILE)
ATX-MS-1467 in Multiple Sclerosis
Psychiatric disorders in patients with multiple sclerosis.
Non-local robust detection of DTI white matter differences with small databases.
Low dose naltrexone for induction of remission in Crohn's disease.
Early phenotypic asymmetry of sister oligodendrocyte progenitor cells after mitosis and its modulation by aging and extrinsic factors.
Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.
Cognitive Impairment in Multiple Sclerosis.
Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
Disc swelling and mild initial visual acuity loss predict a better short-term visual acuity outcome in bilateral acute optic neuritis.
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.
Prognostic indicators for long-term disability in multiple sclerosis patients.
Diffusion tensor imaging of acute inflammatory lesion evolution in multiple sclerosis.
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.
Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MS.
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
215
216
217
218
219
220
221
222
223
…
next ›
last »